FDA inspection

Regeneron Pharmaceuticals Inc: FDA inspection ending Apr 3, 2015

FDA inspection 926255 · Voluntary Action Indicated (VAI) · Rensselaer, NY

Key facts

Inspection ID 926255
Firm Regeneron Pharmaceuticals Inc
FEI number 1000514603
Address 81 Columbia Tpke
City Rensselaer
State NY
ZIP 12144-3411
Fiscal year 2015
Inspection end date Apr 3, 2015
Classification Voluntary Action Indicated (VAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections